PharmaCyte Biotech Inc Sustainability Reports
A clinical-stage biotechnology company developing cellular therapies for cancer and diabetes using its proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.”
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG001S69496
3 reports from 2022 to 2024
